Multiple sclerosis drug mitoxantrone may be linked to increased risk of colorectal cancer

The multiple sclerosis (MS) drug mitoxantrone may be associated with an increased risk of colorectal cancer, according to a study. Mitoxantrone suppresses the immune system. It was first developed as a chemotherapy drug for certain cancers.